CorMedix Inc. (CRMD) Stock

Healthcare · Biotechnology · Member of Other US Stocks

CorMedix Inc. (CRMD) closed at USD 7.39 on 2026-10-14, a change of -33.7 % over the past year, with a market capitalization of USD 581.46M.

CorMedix Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

CorMedix Inc. key figures

Previous close

USD 7.39 (2026-10-14)

1-year change

-33.7 %

Market cap

USD 581.46M

Enterprise value

USD 472.23M

P/E ratio (trailing)

3.64

P/E ratio (forward)

21.31

EPS (trailing)

2.05

EPS (forward)

0.35

PEG ratio

5.28

Price to book

1.26

Revenue growth

156.5 %

Earnings growth

6.7 %

Dividend per share (trailing)

0.00

Short ratio

17.97

Employees

191

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About CorMedix Inc.

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for CorMedix Inc. and compare it with other stocks.